The ROE as of December 2025 (TTM) for TransCode Therapeutics, Inc. (RNAZ) is -1354.71%

According to TransCode Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -1354.71%. This represents a change of 2.21% compared to the average of -58.62% of the last 4 quarters.

TransCode Therapeutics, Inc. (RNAZ) Historical ROE (quarterly & annually)

How has RNAZ ROE performed in the past?

The mean historical ROE of TransCode Therapeutics, Inc. over the last ten years is -168.45%. The current -1354.71% ROE has changed 704.20% with respect to the historical average. Over the past ten years (40 quarters), RNAZ's ROE was at its highest in in the March 2023 quarter at 2.03%. The ROE was at its lowest in in the December 2022 quarter at -568.07%.

TransCode Therapeutics, Inc. (RNAZ) ROE by Quarter and Year

Discovering the peaks and valleys of TransCode Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TransCode Therapeutics, Inc. (RNAZ) Average ROE

How has RNAZ ROE performed in the past?

The current ROE of TransCode Therapeutics, Inc. (RNAZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

TransCode Therapeutics, Inc. (RNAZ) ROE vs. Peers

How is RNAZ’s ROE compared to its peers?

TransCode Therapeutics, Inc.’s ROE is greater than IN8bio, Inc. (-145.52%), greater than Lyra Therapeutics, Inc. (-411.98%), greater than Aptevo Therapeutics Inc. (-675.52%), greater than Galecto, Inc. (-130.67%), greater than Phio Pharmaceuticals Corp. (-86.38%), less than HCW Biologics Inc. (507.82%), greater than Kiora Pharmaceuticals, Inc. (-47.17%), greater than Aprea Therapeutics, Inc. (-75.30%), greater than Bolt Biotherapeutics, Inc. (-97.58%), greater than Acurx Pharmaceuticals, Inc. (-219.56%),

Build a custom stock screener for TransCode Therapeutics, Inc. (RNAZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TransCode Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TransCode Therapeutics, Inc. (RNAZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TransCode Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.